Literature DB >> 12971940

Cross cultural evaluation of smokers risk for panic and anxiety pathology: a test in a Russian epidemiological sample.

Michael J Zvolensky1, Roman Kotov, Anna V Antipova, Norman B Schmidt.   

Abstract

The present study evaluated the main and interactive effects of level of smoking (cigarettes per day) and anxiety sensitivity (fear of anxiety and anxiety related sensations) in predicting panic and anxiety variables in an epidemiologically-defined sample of smokers from Moscow (n=95). The combination of high levels of anxiety sensitivity and smoking predicted agoraphobic avoidance, but not frequency of panic attacks during the past week. These findings suggest anxiety sensitivity may moderate the relation between level of smoking and prototypical panic psychopathology variables (panic attacks and agoraphobic avoidance) even after controlling for the theoretically-relevant factors of alcohol abuse and negative affect.

Entities:  

Mesh:

Year:  2003        PMID: 12971940     DOI: 10.1016/s0005-7967(03)00031-7

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  23 in total

Review 1.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

Review 2.  Applying the tripartite model of anxiety and depression to cigarette smoking: an integrative review.

Authors:  Katherine J Ameringer; Adam M Leventhal
Journal:  Nicotine Tob Res       Date:  2010-10-29       Impact factor: 4.244

Review 3.  Distress tolerance and early smoking lapse.

Authors:  Richard A Brown; C W Lejuez; Christopher W Kahler; David R Strong; Michael J Zvolensky
Journal:  Clin Psychol Rev       Date:  2005-09

4.  An integrated approach to panic prevention targeting the empirically supported risk factors of smoking and anxiety sensitivity: theoretical basis and evidence from a pilot project evaluating feasibility and short-term efficacy.

Authors:  Matthew T Feldner; Michael J Zvolensky; Kimberly Babson; Ellen W Leen-Feldner; Norman B Schmidt
Journal:  J Anxiety Disord       Date:  2008-01-11

5.  The Moderating Effect of Smoking Status on the Relation between Anxiety Sensitivity, Sexual Compulsivity, and Suicidality among People with HIV/AIDS.

Authors:  Charles Philip Brandt; Jafar Bakhshaie; Charles Jardin; Chad Lemaire; Brooke Y Kauffman; Carla Sharp; Michael J Zvolensky
Journal:  Int J Behav Med       Date:  2017-02

Review 6.  Panic attacks, panic disorder, and agoraphobia: associations with substance use, abuse, and dependence.

Authors:  Michael J Zvolensky; Amit Bernstein; Erin C Marshall; Matthew T Feldner
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

7.  Anxiety sensitivity and opioid misuse among opioid-using adults with chronic pain.

Authors:  Andrew H Rogers; Brooke Y Kauffman; Jafar Bakhshaie; R Kathryn McHugh; Joseph W Ditre; Michael J Zvolensky
Journal:  Am J Drug Alcohol Abuse       Date:  2019-03-21       Impact factor: 3.829

8.  Main and interactive effects of emotion dysregulation and breath-holding duration in relation to panic-relevant fear and expectancies about anxiety-related sensations among adult daily smokers.

Authors:  Charles P Brandt; Kirsten A Johnson; Norman B Schmidt; Michael J Zvolensky
Journal:  J Anxiety Disord       Date:  2011-11-06

9.  Anxiety sensitivity as a moderator of the association between smoking status and anxiety symptoms and bodily vigilance: replication and extension in a young adult sample.

Authors:  Alison C McLeish; Michael J Zvolensky; Andrew R Yartz; Teresa M Leyro
Journal:  Addict Behav       Date:  2007-09-29       Impact factor: 3.913

10.  Anxiety sensitivity as an amplifier of subjective and behavioral tobacco abstinence effects.

Authors:  Michael J Zvolensky; Samantha G Farris; Casey R Guillot; Adam M Leventhal
Journal:  Drug Alcohol Depend       Date:  2014-06-25       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.